Skip to content

A randomised controlled study to compare the effectiveness of 5% dextrose and triamcinolone in the carpal tunnel syndrome patients who are refractory to conservative therapy

Comparsion of 5% dextrose versus triamcinolone in the carpal tunnel syndrome patients refractory to conservative therapy - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061292
Enrollment
50
Registered
2024-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G629- Polyneuropathy, unspecified

Interventions

Intervention1: median nerve block at wrist joint: ultrasound guided one session of 2 minute duration of perineural median nerve block at the level of wrist joint using 5% dextrose in patients of carpa

Sponsors

Department of anaesthesiology and critical care,Jawaharlal nehru medical college,AMU,aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with mild to moderate Carpal tunnel syndrome with symptoms of Nocturnal paresthesia/dysthesia with or without pain over the subjected, which could be associated with posture or overuse of the wrist, or relieved with shaking motion of the hand may or may not be associated with numbness in the sensory distribution of Median nerve

Exclusion criteria

Exclusion criteria: patients with history of polyneuropathy, brachial plexopathy, thoracic outlet syndrome or wrist surgery. patients with History of inflammatory arthritis, hypothyroidism, pregnancy, and rheumatological disorder or having pacemaker. patients who are on warfarin use, previous steroid injection for CTS, trauma or neoplasm at injection site, hypersensitivity to corticosteroid, skin infection at site of infection

Design outcomes

Primary

MeasureTime frame
to compare the efficacy of 5% dextrose versus triamcinolone injectionTimepoint: Both the groups will be assessed prior to injection and 1,3, and 6 weeks post injection

Secondary

MeasureTime frame
study the side effects and complications of drugs usedTimepoint: during the follow up period of 6 weeks any complications related to drug administered

Countries

India

Contacts

Public ContactDewanshi Agrawal

Jawaharlal nehru medical college,aligarh muslim university,aligarh

hussainamir77@gmail.com9897559183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026